Sarosiek, K. ., Jones, E. ., Chipitsyna, G. ., Al-Zoubi, M. ., Kang, C. ., Saxena, S. ., … Arafat, H. . (2015). Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? A new role for OPN. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract, 19(4), 639-50. https://doi.org/10.1007/s11605-014-2735-6

Saxena, S. ., Gandhi, A. ., Lim, P. ., Relles, D. ., Sarosiek, K. ., Kang, C. ., … Arafat, H. . (2013). RAN GTPase and Osteopontin in Pancreatic Cancer. Pancreatic Disorders & Therapy, 3(1), 113. (Original work published 2013)

Al-Zoubi, M. ., Chipitsyna, G. ., Saxena, S. ., Sarosiek, K. ., Gandhi, A. ., Kang, C. ., … Arafat, H. . (2014). Overexpressing TNF-alpha in pancreatic ductal adenocarcinoma cells and fibroblasts modifies cell survival and reduces fatty acid synthesis via downregulation of sterol regulatory element binding protein-1 and activation of acetyl CoA carboxylase. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract, 18(2), 257-68; discussion 268. https://doi.org/10.1007/s11605-013-2370-7

Gandhi, A. ., Saxena, S. ., Relles, D. ., Sarosiek, K. ., Kang, C. ., Chipitsyna, G. ., … Arafat, H. . (2013). Differential expression of cytochrome P450 omega-hydroxylase isoforms and their association with clinicopathological features in pancreatic ductal adenocarcinoma. Annals of Surgical Oncology, 20 Suppl 3, S636-43. https://doi.org/10.1245/s10434-013-3128-x